A Phase II Study of Gefitinib in Patients with Advanced Thyroid CancerNathan A. Pennell, Thomas J. Lynch, Panos Fidias et al.|Thyroid|2007Cited by 198
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)Sewanti Limaye, Robert I. Haddad, Sarah Riley et al.|Oral Oncology|2013Cited by 59
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinomaGlenn J. Hanna, Robert I. Haddad, Leonard I. Zon et al.|Oral Oncology|2021Cited by 51